Synthesis and biological evaluation of a selective N- and P/Q-Type calcium channel agonist

ACS Medicinal Chemistry Letters

Volumn 3, Issue 12, 2012, Pages 985-990

  Liang, Mary ^a   Tarr, Tyler B ^b   Bravo Altamirano, Karla ^a   Valdomir, Guillermo ^a   Rensch, Gabriel ^a   Swanson, Lauren ^a   Destefino, Nicholas R ^b   Mazzarisi, Cara M ^b   Olszewski, Rachel A ^b   Wilson, Gabriela Mustata ^b   Meriney, Stephen D ^b   Wipf, Peter ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

cdk2; Lambert Eaton myasthenic syndrome; LEMS; N P Q type calcium channels; neurological autoimmune disorder; roscovitine; selective agonist

Indexed keywords

CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CALCIUM CHANNEL STIMULATING AGENT; CYCLIN DEPENDENT KINASE INHIBITOR; ROSCOVITINE;

ARTICLE; AUTOIMMUNE DISEASE; BIOLOGICAL ACTIVITY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; EATON LAMBERT SYNDROME; ENZYME ACTIVITY; HUMAN; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL;

EID: 84871211807     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml3002083     Document Type: Article

References (29)

1. Urbano, F. J.; Pagani, M. R.; Uchitel, O. D. Calcium channels, neuromuscular synaptic transmission and neurological diseases J. Neuroimmunol. 2008, 201-202, 136-144
2. Motomura, M.; Lang, B.; Johnston, I.; Palace, J.; Vincent, A.; Newsom-Davis, J. Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome J. Neurol. Sci. 1997, 147, 35-42
3. Seagar, M.; Léveîque, C.; Charvin, N.; Marquèze, B.; Martin-Moutot, N.; Boudier, J. A.; Boudier, J. L.; Shoji-Kasai, Y.; Sato, K.; Takahashi, M. Interactions between proteins implicated in exocytosis and voltage-gated calcium channels Philos. Trans. R. Soc. B, 1999, 354, 289-97
4. Lindquist, S.; Stangel, M. Update on treatment options for Lambert-Eaton myasthenic syndrome: Focus on use of amifampridine Neuropsychiatr. Dis. Treat. 2011, 7, 341-349
5. Sanders, D. B. Lambert-Eaton myasthenic syndrome: Diagnosis and treatment Ann. N.Y. Acad. Sci. 2003, 998, 500-508
6. Meijer, L.; Raymond, E. Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials Acc. Chem. Res. 2003, 36, 417-425
7. Meijer, L.; Bettayeb, K.; Galons, H. (R)-Roscovitine (cyc202, seliciclib). In Inhibitors of Cyclin-Dependent Kinases as Anti-Tumor Agents; Smith, P. J.; Yue, E. W., Eds.; CRC/Taylor & Francis: Boca Raton, 2007; pp 187-225.
8. Cho, S.; Meriney, S. D. The effects of presynaptic calcium channel modulation by roscovitine on transmitter release at the adult frog neuromuscular junction Eur. J. Neurosci. 2006, 23, 3200-3208
9. De Stefino, N. R.; Pilato, A. A.; Dittrich, M.; Cherry, S. V.; Cho, S.; Stiles, J. R.; Meriney, S. D. (R)-Roscovitine prolongs the mean open time of unitary N-type calcium channel currents Neuroscience 2010, 167, 838-849
10. Yan, Z.; Chi, P.; Bibb, J. A.; Ryan, T. A.; Greengard, P. Roscovitine: A novel regulator of P/Q-type calcium channels and transmitter release in central neurons J. Physiol. 2002, 540, 761-70
11. Buraei, Z.; Anghelescu, M.; Elmslie, K. S. Slowed N-type calcium channel (CaV2.2) deactivation by the cyclin-dependent kinase inhibitor roscovitine Biophys. J. 2005, 89, 1681-1691
12. v2.2 (N-type) channels J. Neurochem. 2008, 105, 1450-1461
13. Sheng, Z.-H.; Westenbroek, R. E.; Catterall, W. A. Physical link and functional coupling of presynaptic calcium channels and the synaptic vesicle docking/fusion machinery J. Bioenerg. Biomembr. 1998, 30, 335-345
14. For a discussion of SAR effects pertaining to the cdk2 activity profile of roscovitine, see Otyepka, M.; Krystof, V.; Havlicek, L.; Siglerova, V.; Strnad, M.; Koca, J. Docking-based development of purine-like inhibitors of cyclin-dependent kinase-2 J. Med. Chem. 2000, 43, 2506-2513
15. Popowycz, F.; Fournet, G.; Schneider, C.; Bettayeb, K.; Ferandin, Y.; Lamigeon, C.; Tirado, O. M.; Mateo-Lozano, S.; Notario, V.; Colas, P.; Bernard, P.; Meijer, L.; Joseph, B. Pyrazolo[1,5- a ]-1,3,5-triazine as a purine bioisostere: Access to potent cyclin-dependent kinase inhibitor (R)-roscovitine analogue J. Med. Chem. 2009, 52, 655-663
16. Oumata, N.; Bettayeb, K.; Ferandin, Y.; Demange, L.; Lopez-Giral, A.; Goddard, M.-L.; Myrianthopoulos, V.; Mikros, E.; Flajolet, M.; Greengard, P.; Meijer, L.; Galons, H. Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1 J. Med. Chem. 2008, 51, 5229-5242
17. Bettayeb, K.; Sallam, H.; Ferandin, Y.; Popowycz, F.; Fournet, G.; Hassan, M.; Echalier, A.; Bernard, P.; Endicott, J.; Joseph, B.; Meijer, L. N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine Mol. Cancer Ther. 2008, 7, 2713-2724
18. Meriney, S. D. Unpublished results.
19. v2.2 channels modulates channel kinetics J. Neurophys. 2004, 92, 2820-2830
20. White, M. G.; Crumling, M. A.; Meriney, S. D. Developmental changes in calcium current pharmacology and somatostatin inhibition of calcium current in chick parasympathetic neurons J. Neurosci. 1997, 17, 6302-6313
21. Yazejian, B.; DiGregorio, D. A.; Vergara, J. L.; Poage, R. E.; Meriney, S. D.; Grinnell, A. D. Direct measurements of presynaptic calcium and calcium-Activated potassium currents regulating neurotransmitter release at cultured Xenopus nerve-muscle synapses J. Neurosci. 1997, 17, 2990-3001
22. Cho, S.; Meriney, S. D. The effects of presynaptic calcium channel modulation by roscovitine on transmitter release at the adult frog neuromuscular junction Eur. J. Neurosci. 2006, 23, 3200-3208
23. Bettayeb, K.; Oumata, N.; Echalier, A.; Ferandin, Y.; Endicott, J. A.; Galons, H.; Meijer, L. CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases Oncogene 2008, 27, 5797-5807
24. Thompson, E. E.; Kornev, A. P.; Kannan, N.; Kim, C.; Ten Eyck, L. F.; Taylor, S. S. Comparative surface geometry of the protein kinase family Protein Sci. 2009, 18, 2016-2026
25. For selective replacements of heterocyclic chloride substituents with carbon nucleophiles, see, for example, Wipf, P.; George, K. M. Regioselective palladium-catalyzed cross-coupling reactions of 2,4,7-trichloroquinazoline Synlett 2010, 644-648
26. Oumata, N.; Ferandin, Y.; Meijer, L.; Galons, H. Practical synthesis of roscovitine and CR8 Org. Process Res. Dev. 2009, 13, 641-644
27. 31P MRS: A quantitative review NMR Biomed. 2007, 20, 555-565
28. Oh, S. J.; Claussen, G. G.; Hatanaka, Y.; Morgan, M. B. 3,4-Diaminopyridine is more effective than placebo in a randomized, double-blind, cross-over drug study in LEMS Muscle Nerve 2009, 40, 795-800
29. Titulaer, M. J.; Lang, B.; Verschuuren, J. J. Lambert-Eaton myasthenic syndrome: From clinical characteristics to therapeutic strategies Lancet Neurol. 2011, 10, 1098-1107